<DOC>
	<DOCNO>NCT01744756</DOCNO>
	<brief_summary>A study research whether subconjunctival bevacizumab injection may potentially suppress neovascularization pterygium , retard decrease size recurrent pterygium .</brief_summary>
	<brief_title>Subconjunctival Bevacizumab Recurrent Pterygium</brief_title>
	<detailed_description>1 . Pacients recurrent pterygium 2 . Anti-VEGF therapy -Bevacizumab</detailed_description>
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Recurrent pterygium Pregnant lactate woman History myocardial infarction History stroke</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Subconjunctival Bevacizumab</keyword>
	<keyword>Recurrent pterygium</keyword>
</DOC>